27464 Bimekizumab vs adalimumab in plaque psoriasis: Higher efficacy translates into improvements in quality of life in the BE SURE multicenter, randomized, double-blinded phase 3 trial

Andrew Blauvelt; Diamant Thaçi; Kim A. Papp; Joseph F. Merola; Eva Cullen; Veerle Vanvoorden; Valerie Ciaravino; Luke Peterson; Kenneth Gordon

doi:10.1016/j.jaad.2021.06.597

27464 Bimekizumab vs adalimumab in plaque psoriasis: Higher efficacy translates into improvements in quality of life in the BE SURE multicenter, randomized, double-blinded phase 3 trial

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2021.06.597 ◽

2021 ◽

Vol 85 (3) ◽

pp. AB146

Author(s):

Andrew Blauvelt ◽

Diamant Thaçi ◽

Kim A. Papp ◽

Joseph F. Merola ◽

Eva Cullen ◽

...

Keyword(s):

Quality Of Life ◽

Plaque Psoriasis ◽

Phase 3 ◽

Double Blinded

Download Full-text

Bimekizumab Versus Ustekinumab in Plaque Psoriasis: Lasting Efficacy Translates to Rapid and Sustained Improvements in Quality of Life in the BE VIVID Multicenter, Randomized, Double-Blinded Phase 3 Trial

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.5.supp.17 ◽

2021 ◽

Vol 5 (1) ◽

pp. s17

Author(s):

K Gordon ◽

P Foley ◽

P Rich ◽

K Duffin ◽

A Pinter ◽

...

Keyword(s):

Quality Of Life ◽

Plaque Psoriasis ◽

Phase 3 ◽

Double Blinded

Abstract not available.

Download Full-text

Long-Term Improvements in Health-Related Quality of Life of Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Results from the CIMPASI-1 and CIMPASI-2 Phase 3 Trials

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.5.supp.20 ◽

2021 ◽

Vol 5 (1) ◽

pp. s20

Author(s):

D Thaçi ◽

A Blauvelt ◽

K Reich ◽

RB Warren ◽

V Piguet ◽

...

Keyword(s):

Quality Of Life ◽

Plaque Psoriasis ◽

Certolizumab Pegol ◽

Health Related Quality ◽

Phase 3 ◽

Severe Plaque Psoriasis ◽

Related Quality ◽

Health Related

Abstract not available.

Download Full-text

Bimekizumab provides rapid and sustained improvements in quality of life that correlate with clinical outcomes in patients with moderate to severe plaque psoriasis: 60 week results from a randomized , double blinded , Phase 2b extension study

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.35 ◽

2019 ◽

Vol 3 ◽

pp. S35

Author(s):

Kim A Papp ◽

Joseph F Merola ◽

Alice B Gottlieb ◽

Christopher EM Griffiths ◽

Kristina K Harris ◽

...

Keyword(s):

Quality Of Life ◽

Clinical Outcomes ◽

Plaque Psoriasis ◽

Extension Study ◽

Severe Plaque Psoriasis ◽

Double Blinded

Abstract not available.

Download Full-text

Efficacy of Apremilast on Quality-of-Life Measures in Patients with Moderate Plaque Psoriasis (UNVEIL Phase IV Study)

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.1.supp.12 ◽

2017 ◽

Vol 1 ◽

pp. s13

Author(s):

Jerry Bagel ◽

Mark Lebwohl ◽

Linda Stein Gold ◽

J Mark Jackson ◽

Joana Goncalves ◽

...

Keyword(s):

Quality Of Life ◽

Plaque Psoriasis ◽

Quality Of Life Measures ◽

Phase Iv

Abstract Not Available Study supported by Celgene.

Download Full-text

Faculty Opinions recommendation of Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717976556.793472766 ◽

2013 ◽

Author(s):

David Kushner ◽

Ryan Spencer

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

International Collaboration ◽

Ovarian Neoplasms ◽

Randomised Trial ◽

Advanced Ovarian Cancer ◽

Life Outcomes ◽

Standard Chemotherapy ◽

Phase 3

Download Full-text

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(20)30581-7 ◽

2021 ◽

Vol 22 (2) ◽

pp. 235-245

Author(s):

Per Fransson ◽

Per Nilsson ◽

Adalsteinn Gunnlaugsson ◽

Lars Beckman ◽

Björn Tavelin ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Life Outcomes ◽

Phase 3 ◽

Fractionated Radiotherapy ◽

Quality Of Life Outcomes ◽

Patient Reported ◽

Randomised Controlled ◽

Conventionally Fractionated

Download Full-text

BG-12 effects on quality of life in relapsing–/INS;remitting ms patients: Integrated analysis of the Phase 3 DEFINE and CONFIRM studies

Journal of the Neurological Sciences ◽

10.1016/j.jns.2013.07.1346 ◽

2013 ◽

Vol 333 ◽

pp. e368 ◽

Cited By ~ 1

Author(s):

M. Kita ◽

R.J. Fox ◽

R. Gold ◽

G. Giovannoni ◽

J.T. Phillips ◽

...

Keyword(s):

Quality Of Life ◽

Integrated Analysis ◽

Phase 3

Download Full-text

The effectiveness of high-intensity laser therapy on pain, range of motion, functional capacity, quality of life, and muscle strength in subacromial impingement syndrome: a 3-month follow-up, double-blinded, randomized, placebo-controlled trial

Lasers in Medical Science ◽

10.1007/s10103-020-03224-7 ◽

2021 ◽

Author(s):

Muhammed Yılmaz ◽

Selma Eroglu ◽

Umit Dundar ◽

Hasan Toktas

Keyword(s):

Quality Of Life ◽

Muscle Strength ◽

Controlled Trial ◽

Subacromial Impingement Syndrome ◽

Subacromial Impingement ◽

High Intensity Laser ◽

Double Blinded ◽

Intensity Laser

Download Full-text

EFFECT OF DARATUMUMAB, BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE ON CARDIAC FUNCTION AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH CARDIAC INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(21)04658-1 ◽

2021 ◽

Vol 77 (18) ◽

pp. 3304

Author(s):

Martha Grogan ◽

Mathew S. Maurer ◽

Ronald Witteles ◽

Divaya Bhutani ◽

Raymond L. Comenzo ◽

...

Keyword(s):

Quality Of Life ◽

Cardiac Function ◽

Cardiac Involvement ◽

Al Amyloidosis ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase 3 ◽

Related Quality ◽

Health Related

Download Full-text

HEALTH‐RELATED QUALITY OF LIFE AMONG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL) IN A PHASE 3 STUDY OF PEMBROLIZUMAB VERSUS BRENTUXIMAB VEDOTIN

Hematological Oncology ◽

10.1002/hon.105_2880 ◽

2021 ◽

Vol 39 (S2) ◽

Author(s):

P. L. Zinzani ◽

M. Raut ◽

T. Saretsky ◽

R. Ramchandren ◽

A. Santoro ◽

...

Keyword(s):

Quality Of Life ◽

Hodgkin Lymphoma ◽

Brentuximab Vedotin ◽

Classical Hodgkin Lymphoma ◽

Health Related Quality ◽

Phase 3 ◽

Related Quality ◽

Health Related

Download Full-text